Is it appropriate to use SBRT on unresectable pancreatic tumors invading the duodenum?

Duodenal invasion would be considered an absolute contraindication to SBRT at our institution. If you look at the early SBRT experiences, such as the Danish phase II trial (PMID 15990186) which treated with larger margins than we use today and did not pay as close attention to the duodenal dose, the...